Fennec Pharmaceuticals (FRX) News Today → 2024's Must-Have Guide: Master Crypto Investment Today (From Darwin) (Ad) Free FRX Stock Alerts C$12.82 -0.95 (-6.90%) (As of 11:27 AM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisChartCompetitorsEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineFennec Pharmaceuticals Inc. (TSE:FRX) Senior Officer Adrian J. Haigh Acquires 22,222 Sharesinsidertrades.com - April 17 at 5:14 AMAdrian J. Haigh Buys 22,222 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) Stockmarketbeat.com - April 16 at 6:28 PMInsider Sell: CEO Rosty Raykov Sells 88,583 Shares of Fennec Pharmaceuticals Inc (FENC)finance.yahoo.com - April 5 at 7:09 PMFRX:CA Fennec Pharmaceuticals Inc.seekingalpha.com - April 1 at 8:45 AMChris Anigeron Rallis Sells 2,114 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) Stockinsidertrades.com - March 31 at 6:12 AMFennec Pharmaceuticals Inc. (FENC) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 23 at 7:06 PMFennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 22 at 9:56 AMWedbush Comments on Fennec Pharmaceuticals Inc.'s Q3 2024 Earnings (TSE:FRX)marketbeat.com - March 22 at 8:18 AMFennec Pharmaceuticals Inc.: Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Updatefinanznachrichten.de - March 21 at 8:55 AMWedbush Research Analysts Cut Earnings Estimates for Fennec Pharmaceuticals Inc. (TSE:FRX)marketbeat.com - March 20 at 6:39 AMStocks in play: Fennec Pharmaceuticals Inc.ca.finance.yahoo.com - March 19 at 12:32 PMFennec Pharmaceuticals Inc. to Post Q2 2024 Earnings of $0.12 Per Share, Wedbush Forecasts (TSE:FRX)marketbeat.com - March 19 at 6:55 AMFennec, Norgine Reach Licensing Deal To Commercialize Pedmarqsi In Europe, Australia, & New Zealandmarkets.businessinsider.com - March 17 at 11:47 PMFennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Resultsfinance.yahoo.com - February 29 at 7:09 AMFENC Mar 2024 10.000 callfinance.yahoo.com - February 23 at 7:59 AMAnalysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and Societal CDMO (SCTL)markets.businessinsider.com - February 1 at 3:27 PMWith 31% stake, Fennec Pharmaceuticals Inc. (NASDAQ:FENC) seems to have captured hedge funds investors' interestfinance.yahoo.com - December 6 at 7:29 AMFennec Pharmaceuticals Inc FRXmorningstar.com - December 1 at 2:43 PMFennec Pharmaceuticals Expands Possible TAM Significantlyseekingalpha.com - November 9 at 8:28 PMFennec Pharmaceuticals Inc. (NASDAQ:FENC) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimatesfinance.yahoo.com - November 9 at 10:27 AMFennec Pharmaceuticals Inc. (NASDAQ:FENC) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 7 at 1:03 PMQ3 2023 Fennec Pharmaceuticals Inc Earnings Callfinance.yahoo.com - November 7 at 8:03 AMPreview: Fennec Pharmaceuticals's Earningsbenzinga.com - November 3 at 6:38 PMInvestors in Fennec Pharmaceuticals (NASDAQ:FENC) have unfortunately lost 20% over the last yearfinance.yahoo.com - November 1 at 2:53 PMFennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023finance.yahoo.com - October 30 at 8:10 AMAnalysts Expect Breakeven For Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Before Longfinance.yahoo.com - October 5 at 1:16 PMClosing Bell: Fennec Pharmaceuticals Inc up on Friday (FRX)theglobeandmail.com - September 30 at 9:16 AMFennec Pharmaceuticals: Top 10 Undervalued Healthcare Sector Stocks on TSX (FRX)theglobeandmail.com - August 23 at 9:16 AMClosing Bell: Fennec Pharmaceuticals Inc down on Wednesday (FRX)theglobeandmail.com - May 25 at 10:08 AMFennec nears European approval for its lead drugbizjournals.com - May 18 at 5:38 PMClosing Bell: Fennec Pharmaceuticals Inc up on Monday (FRX)theglobeandmail.com - May 16 at 7:51 AMFennec Pharmaceuticals to Report First Quarter 2023 Financial Results on May 11, 2023finance.yahoo.com - May 8 at 10:07 AMFennec Pharmaceuticals Inc. (FRX.TO)finance.yahoo.com - May 4 at 8:31 PMClosing Bell: Fennec Pharmaceuticals Inc up on Tuesday (FRX)theglobeandmail.com - May 3 at 7:57 PMClosing Bell: Fennec Pharmaceuticals Inc flat on Monday (FRX)theglobeandmail.com - May 2 at 7:44 PMWhen Will Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Become Profitable?finance.yahoo.com - April 28 at 1:06 PMClosing Bell: Fennec Pharmaceuticals Inc down on Monday (FRX)theglobeandmail.com - April 26 at 3:23 AMClosing Bell: Fennec Pharmaceuticals Inc flat on Thursday (FRX)theglobeandmail.com - April 21 at 1:07 AMClosing Bell: Fennec Pharmaceuticals Inc down on Tuesday (FRX)theglobeandmail.com - April 20 at 3:07 PMClosing Bell: Fennec Pharmaceuticals Inc flat on Friday (FRX)theglobeandmail.com - April 19 at 8:55 AMClosing Bell: Fennec Pharmaceuticals Inc down on Friday (FRX)theglobeandmail.com - April 15 at 2:48 PMClosing Bell: Fennec Pharmaceuticals Inc down on Thursday (FRX)theglobeandmail.com - April 13 at 6:07 PMClosing Bell: Fennec Pharmaceuticals Inc up on Thursday (FRX)theglobeandmail.com - April 7 at 6:09 PMClosing Bell: Fennec Pharmaceuticals Inc up on Wednesday (FRX)theglobeandmail.com - April 6 at 5:06 PMInvestors in Fennec Pharmaceuticals (NASDAQ:FENC) have made a notable return of 52% over the past three yearsfinance.yahoo.com - April 1 at 9:27 AMFennec Pharmaceuticals Receives Positive CHMP Opinion for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patientsfinance.yahoo.com - March 31 at 8:21 AMWhy Earnings Season Could Be Great for Adherex Technologies (FENC)finance.yahoo.com - February 23 at 3:58 PMFY2022 EPS Estimates for Fennec Pharmaceuticals Inc. Lowered by Analyst (TSE:FRX)marketbeat.com - January 30 at 1:13 AMFennec Pharmaceuticals Announces Updated NCCN Clinical Practice Guidelinestmcnet.com - January 25 at 9:59 AMFennec Pharmaceuticals Announces Updated NCCN Clinical Practice Guidelines Recommend PEDMARK® (sodium thiosulfate injection) to Reduce the Risk of Cisplatin-Induced Hearing Loss in Pediatric Patientsfinance.yahoo.com - January 25 at 9:59 AM Get Fennec Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for FRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Special FREE offer on stock hotsheets (Ad)These sheets tell you the exact day you should consider buying a stock… And the exact day you should consider selling it… All based on TEN YEARS of historic data and trends. For example, like January 6th through the 12th with Apple… It’s gone up every single year for the last decade. Or like May 26th through June 11th with LULU… Again - it’s gone up every single year for the last decade. Then there’s July 1st through the 21st with Walmart… What happened to WMT? Click here and I’ll show you FRX Media Mentions By Week FRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FRX News Sentiment▼1.050.52▲Average Medical News Sentiment FRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FRX Articles This Week▼40▲FRX Articles Average Week Get Fennec Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for FRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SVA News Today MDNA News Today ONC News Today VMD News Today CARE News Today OPS News Today ACB News Today KSI News Today VHI News Today DR News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:FRX) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIThe #1 Crypto for 2024InvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsUrgent alert: open this for a huge profit potentialTimothy Sykes1970’s computer coder issues shocking A.I. warningTradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fennec Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.